Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis

Aliment Pharmacol Ther. 2021 Jan;53(1):213-214. doi: 10.1111/apt.16164.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Hepatitis B e Antigens
  • Hepatitis B virus
  • Hepatitis B, Chronic* / complications
  • Hepatitis B, Chronic* / pathology
  • Humans
  • Inflammation / pathology
  • Liver / pathology
  • Liver Cirrhosis / pathology
  • Probability

Substances

  • Hepatitis B e Antigens